Skip to main content
Premium Trial:

Request an Annual Quote

Phoenix S&T Nets $500K from Southeast Pennsylvania Greenhouse

NEW YORK (GenomeWeb News) – Biomolecular analysis and proteomics company Phoenix S&T has received a $500,000 investment from BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania.
 
BioAdvance said today that it has provided the Chester, Pa.-based company with the funding as one of three firms it has newly invested in with a total of $1.5 million.
 
PST has patented injection molded nanospray devices used in biomolecular analysis for proteomics and clinical diagnostics applications.
 
BioAdvance derives funding from the $20 million Greenhouse Fund that was established in 2002. It provides initial seed funds of up to $500,000, and it provides business assistance and other resources.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more